EODData

SHE, 301277: Henan Newland Pharmaceutical Co. Ltd. A

10 Aug 2026
LAST:

10.75

CHANGE:
 0.04
OPEN:
10.77
HIGH:
10.95
ASK:
0.00
VOLUME:
9.42M
CHG(%):
0.37
PREV:
10.79
LOW:
10.67
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Aug 2610.7710.9510.6710.759.42M
07 Aug 2610.2110.8010.1510.7911.97M
06 Aug 2610.4410.4710.1510.245.94M
05 Aug 2610.3610.4810.2110.376.97M
04 Aug 269.8810.709.8510.4310.87M
03 Aug 269.729.839.699.822.71M
31 Jul 269.689.799.469.723.33M
30 Jul 269.689.989.479.504.97M
29 Jul 269.689.849.609.804.32M
28 Jul 269.6810.289.689.775.93M

PROFILE

Name:Henan Newland Pharmaceutical Co. Ltd. A
About:Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge City, China.
Sector:Healthcare
Address:East side of the southern section of Weiwu Road, Changge City, China, 461500
Website:https://www.newlandpharma.com
ISIN:CNE1000065K2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:37.96 
Price to Sales:5.87 
Price to Book:2.44 
Profit Margin:0.15 
Operating Margin:0.20 
Return on Assets:0.03 
Return on Equity:0.06 
DivYield:0.02 
Div/Share:0.29 
Revenue:659.54M 
EBITDA:173.32M 
Shares:392.08M 
Market Cap:4.215B 

TECHNICAL INDICATORS

MA5:10.522.2%
MA10:10.126.2%
MA20:10.334.1%
MA50:9.7710.1%
MA100:10.601.4%
MA200:11.597.8%
STO9:86.21 
STO14:86.76 
RSI14:58.70
WPR14:-2.96 
MTM14:0.66
ROC14:0.07 
ATR:0.44 
Week High:10.951.9%
Week Low:9.6910.9%
Month High:12.4315.6%
Month Low:9.307.8%
Year High:15.7046.0%
Year Low:8.4527.2%
Volatility:55.49 

RECENT SPLITS

Date Ratio
16 Apr 20251.4-1
10 May 20241.4-1
10 May 20231-1

RECENT DIVIDENDS

Date Amount
16 Apr 2025$0.20
10 May 2024$0.10
10 May 2023$0.13
10 Nov 2022$0.04
11 Aug 2022$0.04
12 May 2022$0.04
17 Feb 2022$0.04
11 Nov 2021$0.04
12 Aug 2021$0.04
06 May 2021$0.04